Matt Sirovich and Jeremy Mindich’s Scopia Capital has reported its passive stake in Neuroderm Ltd (NASDAQ:NDRM) via a 13G filing with the Securities and Exchange Commission. According to the filing, Scopia Capital holds around 14.57% of the company’s outstanding common stock, the position containing 3.14 million shares. Scopia Capital initiated a position in Neuroderm during the third quarter of 2015, reporting 1.34 million shares in its last 13F filing.
You can access the original SEC filing by clicking here.
Ownership Summary Table
|Name||Sole Voting Power||Shared Voting Power||Sole Dispositive Power||Shared Dispositive Power||Aggregate Amount Owned Power||Percent of Class|
|Scopia Capital Management LP I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) 30-0711986||0||3,136,999||0||3,136,999||3,136,999||14.57%|
|Scopia Windmill Fund LP I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) 27-5099941||0||1,876,411||0||1,876,411||1,876,411||8.71%|
|Scopia Health Care International Master Fund LP I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) 98-1234375||0||1,092,198||0||1,092,198||1,092,198||5.07%|
|Matthew Sirovich I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)||0||3,136,999||0||3,136,999||3,136,999||14.57%|
|Jeremy Mindich I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)||0||3,136,999||0||3,136,999||3,136,999||14.57%|
Follow Matt Sirovich And Jeremy Mindich's Scopia Capital
Page 1 of 13 SEC Filing
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
Under the Securities Exchange Act of 1934
|(Name of Issuer)|
|Ordinary Shares, par value NIS 0.01 per share|
|(Title of Class of Securities)|
|January 15, 2016|
|(Date of Event Which Requires Filing of this Statement)|
Check the appropriate box to designate the rule
pursuant to which this Schedule is filed:
|(1)||The remainder of this |
cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
information required in the remainder of this cover page shall not be deemed to be “filed’ for the purpose of Section 18
of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject
to all other provisions of the Act (however, see the Notes).